Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Liqing Ning, Dengju Li, Pingfan Lu & Yimei Que. (2021) Exploring the determinants that influence hospital costs of induction therapy for acute myeloid leukemia. Leukemia & Lymphoma 62:5, pages 1211-1218.
Read now
Read now
Anna B. Halpern, Megan Othus, Nicholas P. Howard, Paul C. Hendrie, Mary-Elizabeth M. Percival, Bart L. Scott, Terry B. Gernsheimer, Nikita V. Baclig, Sarah A. Buckley, Ryan D. Cassaday, Garrett A. Hartley, Verna L. Welch, Elihu H. Estey & Roland B. Walter. (2021) Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid neoplasms. Leukemia & Lymphoma 62:1, pages 234-238.
Read now
Read now
Tamara P. Miller, Kelly D. Getz, Marko Kavcic, Yimei Li, Yuan-Shun V. Huang, Lillian Sung, Todd A. Alonzo, Robert Gerbing, Marla Daves, Terzah M. Horton, Michael A. Pulsipher, Jessica Pollard, Rochelle Bagatell, Alix E. Seif, Brian T. Fisher, Alan S. Gamis & Richard Aplenc. (2016) A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children’s Oncology Group. Leukemia & Lymphoma 57:7, pages 1567-1574.
Read now
Read now
Tom Møller, Lis Adamsen, Charlotte Appel, Pernille Welinder, Maria Stage, Mary Jarden, Maiken Hjerming & Lars Kjeldsen. (2012) Health related quality of life and impact of infectious comorbidity in outpatient management of patients with acute leukemia. Leukemia & Lymphoma 53:10, pages 1896-1904.
Read now
Read now
Sameer Bakhshi, Preetpaul Singh & Chetanya Swaroop. (2009) Outpatient consolidation chemotherapy in pediatric acute myeloid leukemia: a retrospective analysis. Hematology 14:5, pages 255-260.
Read now
Read now
Articles from other publishers (23)
Wenhui Li, Katherine Richter, Jamie Lee, Kevin McCarthy & Timothy Kubal. (2021) Safety and feasibility of outpatient high-dose cytarabine and intermediate-dose cytarabine for consolidation therapy in acute myeloid leukemia. Journal of Oncology Pharmacy Practice 28:8, pages 1812-1818.
Crossref
Crossref
Kelly D. Getz, Julia E. Szymczak, Yimei Li, Rachel Madding, Yuan-Shung V. Huang, Catherine Aftandilian, Staci D. Arnold, Kira O. Bona, Emi Caywood, Anderson B. Collier, M. Monica Gramatges, Meret Henry, Craig Lotterman, Kelly Maloney, Amir Mian, Rajen Mody, Elaine Morgan, Elizabeth A. Raetz, Jeffrey Rubnitz, Anupam Verma, Naomi Winick, Jennifer J. Wilkes, Jennifer C. Yu, Brian T. Fisher & Richard Aplenc. (2021) Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia. JAMA Network Open 4:10, pages e2128385.
Crossref
Crossref
Lindsay Wilde, Alessandro Isidori, Gina Keiffer, Neil Palmisiano & Margaret Kasner. (2020) Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience. Frontiers in Oncology 10.
Crossref
Crossref
Anna B. Halpern, Nicholas P. Howard, Megan Othus, Paul C. Hendrie, Nikita V. Baclig, Sarah A. Buckley, Mary-Elizabeth M. Percival, Pamela S. Becker, Bart L. Scott, Vivian G. Oehler, Terry B. Gernsheimer, Siobán B. Keel, Johnnie J. Orozco, Ryan D. Cassaday, Andrei R. Shustov, Garrett A. Hartley, Verna L. Welch, Elihu H. Estey & Roland B. Walter. (2019) Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm. Leukemia 34:2, pages 635-639.
Crossref
Crossref
Anna B. Halpern, Roland B. Walter & Elihu H. Estey. (2019) Outpatient induction and consolidation care strategies in acute myeloid leukemia. Current Opinion in Hematology 26:2, pages 65-70.
Crossref
Crossref
Katrine S. Fridthjof, Peter Kampmann, Anne Dünweber, Jette S. Gørløv, Connie Nexø, Lone S. Friis, Kristina H. Nørskov, Pernille C. Welinder, Claus Moser, Lars Kjeldsen & Tom Møller. (2018) Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma. British Journal of Haematology 181:5, pages 637-641.
Crossref
Crossref
Anita J. Kumar, Tobi Henzer, Angie Mae Rodday & Susan K. Parsons. (2018)
Risk factors for length of stay and charge per day differ between older and younger hospitalized patients with
AML
. Cancer Medicine 7:6, pages 2744-2752.
Crossref
Crossref
Ali McBride, Christopher J. Campen, James Camamo, Marie Maloney, Daniel Persky, Sandra E. Kurtin, Nikki L. Barket, Ravitharan Krishnadasan, Emad Elquza, Faiz Anwer & Kurt Weibel. (2018) Implementation of a pharmacy-managed program for the transition of chemotherapy to the outpatient setting. American Journal of Health-System Pharmacy 75:9, pages e246-e258.
Crossref
Crossref
Samantha A. Hershenfeld, Kimberly Maki, Lana Rothfels, Cindy S. Murray, Shannon Nixon, Aaron D. Schimmer & Mary C. Doherty. (2017) Sharing post-AML consolidation supportive therapy with local centers reduces patient travel burden without compromising outcomes. Leukemia Research 59, pages 93-96.
Crossref
Crossref
Jeong Yun Park. (2016) Implementing a central venous catheter self-management education program for patients with cancer. European Journal of Oncology Nursing 25, pages 1-8.
Crossref
Crossref
Jennifer E. Vaughn, Sarah A. Buckley & Roland B. Walter. (2016) Outpatient care of patients with acute myeloid leukemia: Benefits, barriers, and future considerations. Leukemia Research 45, pages 53-58.
Crossref
Crossref
Tom Møller, Claus Moser, Lis Adamsen, Grith Rugaard, Mary Jarden, Tina S. Bøtcher, Liza Wiedenbein & Lars Kjeldsen. (2016) Early warning and prevention of pneumonia in acute leukemia by patient education, spirometry, and positive expiratory pressure: A randomized controlled trial. American Journal of Hematology 91:3, pages 271-276.
Crossref
Crossref
Kelly D. Getz, Tamara P. Miller, Alix E. Seif, Yimei Li, Yuan‐Shung Huang, Rochelle Bagatell, Brian T. Fisher & Richard Aplenc. (2015) A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia. Cancer Medicine 4:9, pages 1356-1364.
Crossref
Crossref
Susumu Inoue, Isra’a Khan, Rao Mushtaq, Dawn Carson, Elna Saah & Nkechi Onwuzurike. (2014) Postinduction Supportive Care of Pediatric Acute Myelocytic Leukemia: Should Patients be Kept in the Hospital?. Leukemia Research and Treatment 2014, pages 1-4.
Crossref
Crossref
Lalit Saini, Coleman Rostein, Eshetu G Atenafu & Joseph M Brandwein. (2013) Ambulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. Coli. BMC Infectious Diseases 13:1.
Crossref
Crossref
Lalit Saini, Mark D. Minden, Andre C. Schuh, Karen W.L. Yee, Aaron D. Schimmer, Vikas Gupta, Eshetu G. Atenafu, Cindy Murray, Shannon Nixon & Joseph M. Brandwein. (2011) Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia. American Journal of Hematology 87:3, pages 323-326.
Crossref
Crossref
Tom Møller & Lis Adamsen. (2010) Hematologic Patients' Clinical and Psychosocial Experiences With Implanted Long-term Central Venous Catheter. Cancer Nursing 33:6, pages 426-435.
Crossref
Crossref
Tom Møller, Ove Juul Nielsen, Pernille Welinder, Anne Dünweber, Maiken Hjerming, Claus Moser & Lars Kjeldsen. (2010) Safe and feasible outpatient treatment following induction and consolidation chemotherapy for patients with acute leukaemia. European Journal of Haematology 84:4, pages 316-322.
Crossref
Crossref
Hitoshi Ohno, Chisaki Mizumoto, Yoshihiro Otsuki, Shigeru Oguma & Yataro Yoshida. (2010) The duration of functioning of a subcutaneous implantable port for the treatment of hematological tumors: a single institution-based study. International Journal of Clinical Oncology 15:2, pages 172-178.
Crossref
Crossref
T.Y. Halim, K.W. Song, M.J. Barnett, D.L. Forrest, D.E. Hogge, S.H. Nantel, T.J. Nevill, J.D. Shepherd, C.A. Smith, H.J. Sutherland, C.L. Toze & J.C. Lavoie. (2007) Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia. Annals of Oncology 18:7, pages 1246-1252.
Crossref
Crossref
M.L. Savoie, T.J. Nevil, K.W. Song, D.L. Forrest, D.E. Hogge, S.H. Nantel, J.D. Shepherd, C.A. Smith, H.J. Sutherland, C.L. Toze & J.C. Lavoie. (2006) Shifting to outpatient management of acute myeloid leukemia: a prospective experience. Annals of Oncology 17:5, pages 763-768.
Crossref
Crossref
Pam McGrath, Mary Anne Paton & Nicole Huff. (2004) Beginning treatment for paediatric acute myeloid leukaemia: diagnosis and the early hospital experience. Scandinavian Journal of Caring Sciences 18:4, pages 358-367.
Crossref
Crossref
Alberto Redaelli, Marc F Botteman, Jennifer M Stephens, Suzanne Brandt & Chris L Pashos. (2004) Economic burden of acute myeloid leukemia: a literature review. Cancer Treatment Reviews 30:3, pages 237-247.
Crossref
Crossref